Bausch & Lomb reported $1.4 billion in revenue, up 8% at constant currency, and adjusted earnings per share of $0.34 during the third quarter. Results were mixed, with revenue modestly below FactSet consensus and EPS exceeding expectations. Shares are up 8%.
B&L has a strong commercial position in both contact lens and consumer eye care products, and this should drive solid growth over the long term.
B&L faces stiff competition across all segments that it plays in, and the lack of investment in its pipeline could leave the firm vulnerable to market share losses.
Metric | BLCO | COO | ALC |
|---|---|---|---|
Price/Earnings (Normalized) | 47.47 | 13.50 | 38.45 |
Price/Book Value | 1.17 | 1.42 | 1.59 |
Price/Sales | 1.39 | 2.88 | 3.20 |
Price/Cash Flow | 12.32 | 12.86 | 13.30 |
Metric | BLCO | COO | ALC |
|---|---|---|---|
Quick Ratio | 0.85 | 0.51 | 1.39 |
Current Ratio | 1.56 | 1.22 | 2.50 |
Interest Coverage | 0.96 | 6.18 | 4.39 |
Metric | BLCO | COO | ALC |
|---|---|---|---|
Return on Assets (Normalized) | 2.35% | 7.25% | 5.25% |
Return on Equity (Normalized) | 5.08% | 10.89% | 7.52% |
Return on Invested Capital (Normalized) | 5.19% | 9.02% | 6.49% |
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc ISRG | LOCK|pkHq>@Pp | LOCK|%! | $152B | |||
| Becton Dickinson & Co BDX | LOCK|?& | LOCK|@sD^W | $59B | |||
| Medline Inc Ordinary Shares - Class A MDLN | LOCK|#^K>bC | LOCK|PwMj | $35B | |||
| Alcon Inc ALC | LOCK|$w<@JB< | LOCK|npB@ | $35B | |||
| ResMed Inc RMD | LOCK|D<Mn^wf& | LOCK|c$#$G | $34B | |||
| West Pharmaceutical Services Inc WST | LOCK|l<%S!<x% | LOCK|<d | $29B | |||
| Solventum Corp SOLV | LOCK|gzl$ZZ | LOCK|wr | $15B | |||
| Baxter International Inc BAX | LOCK|Jm | LOCK|$q&t> | $13B | |||
| The Cooper Companies Inc COO | LOCK|$ZYkY# | LOCK|wW@&& | $12B | |||
| Align Technology Inc ALGN | LOCK|%T!<w$ | LOCK|sxq!> | $12B |
United States